News >

Novel Induction Regimens Boost Survival in Newly Diagnosed Myeloma

Kristi Rosa
Published: Tuesday, Aug 13, 2019

Saad Z. Usmani, MD

Saad Z. Usmani, MD
The goal of induction regimens for patients with newly diagnosed multiple myeloma is to reduce the burden of disease and prolong durability of response and overall survival (OS), while minimizing toxicity, Saad Usmani MD, FACP, said during a presentation at the inaugural Charlotte Plasma Cell Disorder Congress.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Briefings™: Individualizing Treatment After Second-Line Therapy for Patients With mCRCAug 29, 20191.0
Community Practice Connections™: Immunotherapeutic Strategies with the Potential to Transform Treatment for Genitourinary CancersAug 29, 20191.0
Publication Bottom Border
Border Publication